News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
76,027 Results
Type
Article (972)
Company Profile (11)
Press Release (75044)
Section
Business (21326)
Career Advice (129)
Deals (8328)
Drug Development (6850)
Employer Resources (2)
FDA (1327)
Job Trends (1568)
News (38381)
Policy (2805)
Tag
2024 Bio NC Digital (2)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (1)
2026 Pharm Country Premier (1)
Academia (88)
Allergies (2)
Alliances (5964)
ALS (8)
Alzheimer's disease (138)
Antibody-drug conjugate (ADC) (4)
Approvals (1340)
Artificial intelligence (7)
Automation (2)
Bankruptcy (84)
Best Places to Work (1399)
Biosimilars (9)
Biotechnology (7)
Bladder cancer (4)
Brain cancer (2)
Breast cancer (21)
Cancer (217)
Cardiovascular disease (7)
Career advice (110)
CAR-T (7)
Cell therapy (27)
Cervical cancer (1)
Clinical research (5836)
Collaboration (60)
Compensation (24)
COVID-19 (92)
C-suite (23)
Cystic fibrosis (10)
Data (220)
Depression (3)
Diabetes (23)
Diagnostics (690)
Digital health (3)
Diversity, equity & inclusion (1)
Drug discovery (6)
Drug pricing (2)
Duchenne muscular dystrophy (3)
Earnings (7472)
Employer branding (1)
Employer resources (2)
Events (10423)
Executive appointments (98)
FDA (1444)
Featured Employer (4)
Frontotemporal dementia (1)
Funding (84)
Gene editing (3)
Gene therapy (8)
GLP-1 (23)
Government (194)
Guidances (3)
Healthcare (2003)
Immunology and inflammation (4)
Indications (3)
Infectious disease (102)
Inflammatory bowel disease (15)
Influenza (5)
Intellectual property (10)
Interviews (23)
IPO (4860)
Job creations (208)
Job search strategy (93)
Layoffs (8)
Legal (900)
Liver cancer (3)
Lung cancer (41)
Lymphoma (11)
Manufacturing (17)
MASH (6)
Medical device (1815)
Medtech (1815)
Mergers & acquisitions (3723)
Metabolic disorders (45)
Multiple sclerosis (6)
NASH (1)
Neurodegenerative disease (2)
Neuroscience (183)
NextGen: Class of 2025 (905)
Non-profit (163)
Northern California (284)
Obesity (17)
Opinion (2)
Ovarian cancer (8)
Pain (9)
Pancreatic cancer (19)
Parkinson's disease (19)
Partnered (3)
Patents (34)
Patient recruitment (13)
Peanut (2)
People (6585)
Pharmacy benefit managers (1)
Phase I (1830)
Phase II (2681)
Phase III (1903)
Pipeline (143)
Policy (1)
Postmarket research (146)
Preclinical (682)
Press Release (1)
Prostate cancer (7)
Psychedelics (1)
Radiopharmaceuticals (44)
Rare diseases (27)
Real estate (525)
Recruiting (1)
Regulatory (1888)
Reports (5)
Research institute (136)
Resumes & cover letters (15)
RSV (3)
Schizophrenia (10)
Series A (6)
Series B (7)
Sickle cell disease (8)
Southern California (290)
Spinal muscular atrophy (2)
Startups (499)
State (1)
Stomach cancer (1)
Supply chain (6)
United States (3080)
Vaccines (23)
Weight loss (2)
Date
Today (19)
Last 7 days (56)
Last 30 days (280)
Last 365 days (4031)
2025 (1101)
2024 (4509)
2023 (5556)
2022 (6780)
2021 (7938)
2020 (7606)
2019 (5319)
2018 (4105)
2017 (3919)
2016 (3238)
2015 (4529)
2014 (3095)
2013 (2535)
2012 (2710)
2011 (2364)
2010 (2117)
Location
Africa (20)
Alabama (2)
Arizona (23)
Arkansas (1)
Asia (4071)
Australia (469)
California (737)
Canada (147)
China (63)
Colorado (21)
Connecticut (46)
Delaware (12)
Europe (5218)
Florida (147)
Georgia (23)
Idaho (7)
Illinois (57)
India (1)
Indiana (55)
Japan (10)
Kansas (19)
Kentucky (1)
Maine (35)
Maryland (97)
Massachusetts (450)
Michigan (61)
Minnesota (42)
Mississippi (2)
Missouri (11)
Montana (2)
Nebraska (3)
Nevada (23)
New Hampshire (9)
New Jersey (268)
New Mexico (2)
New York (287)
North Carolina (184)
Northern California (284)
Ohio (29)
Oregon (2)
Pennsylvania (197)
Rhode Island (3)
South America (64)
South Carolina (6)
Southern California (290)
Tennessee (23)
Texas (161)
Utah (40)
Virginia (24)
Washington D.C. (1)
Washington State (55)
West Virginia (1)
Wisconsin (11)
76,027 Results for "adimab llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Adimab Provides Update on Pipeline
January 14, 2025
·
6 min read
Business
Adimab Provides 2023 Update on Clinical Pipeline
Adimab, LLC today announced that 12 new partner programs entered clinical development in 2023.
January 9, 2024
·
5 min read
Policy
Adimab Announces Successful Resolution of Lawsuit Brought Against LinkedUp Bioscience and Tianti Biotherapeutics
Adimab, LLC announced today that Adimab and LinkedUp Bioscience, Inc. (and related parties) have agreed to resolve litigation.
December 21, 2023
·
5 min read
Policy
LinkedUp Bioscience and TianTi Biotherapeutics Successfully Resolve Legal Dispute with Adimab
LinkedUp Bioscience and TianTi Biotherapeutics are pleased to announce the resolution of the lawsuit brought by Adimab, LLC, and related parties.
January 9, 2024
·
1 min read
Business
Adimab Provides Year-End Update on 2023 Partnership Activities
Adimab, LLC, the global leader in the discovery and engineering of fully human monoclonal and multispecific antibodies, today announced that it entered into partnership agreements with 10 new companies in 2023.
January 8, 2024
·
5 min read
Press Releases
Adimab Announces Hire of Aaron Sato as Chief Strategy Officer
October 17, 2024
·
3 min read
Business
Ablexis Announces License Agreement with Adimab
Ablexis, LLC today announced a license agreement with Adimab, LLC (“Adimab”).
February 9, 2023
·
2 min read
Business
Ono Enters into a Drug Discovery Collaboration Agreement with Adimab to Discover Novel Antibody Drugs in the Oncology Field
Ono Pharmaceutical Co., Ltd. announced that it has entered into a drug discovery collaboration agreement with Adimab, LLC, the global leader in the discovery and optimization of fully human monoclonal and bispecific antibodies, to discover and develop innovative antibody drugs in the oncology field.
September 27, 2023
·
3 min read
Press Releases
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711
April 22, 2025
·
2 min read
Adimab Provides Year-End Update on 2022 Partnership Activities
Adimab, LLC, the global leader in the discovery and optimization of fully human monoclonal and bispecific antibodies, today announced that it entered into partnership agreements with 11 new companies in 2022.
January 10, 2023
·
5 min read
1 of 7,603
Next
